Literature DB >> 23346095

Dysregulated A to I RNA editing and non-coding RNAs in neurodegeneration.

Minati Singh1.   

Abstract

RNA editing is an alteration in the primary nucleotide sequences resulting from a chemical change in the base. RNA editing is observed in eukaryotic mRNA, transfer RNA, ribosomal RNA, and non-coding RNAs (ncRNA). The most common RNA editing in the mammalian central nervous system is a base modification, where the adenosine residue is base-modified to inosine (A to I). Studies from ADAR (adenosine deaminase that act on RNA) mutants in Caenorhabditis elegans, Drosophila, and mice clearly show that the RNA editing process is an absolute requirement for nervous system homeostasis and normal physiology of the animal. Understanding the mechanisms of editing and findings of edited substrates has provided a better knowledge of the phenotype due to defective and hyperactive RNA editing. A to I RNA editing is catalyzed by a family of enzymes knows as ADARs. ADARs modify duplex RNAs and editing of duplex RNAs formed by ncRNAs can impact RNA functions, leading to an altered regulatory gene network. Such altered functions by A to I editing is observed in mRNAs, microRNAs (miRNA) but other editing of small and long ncRNAs (lncRNAs) has yet to be identified. Thus, ncRNA and RNA editing may provide key links between neural development, nervous system function, and neurological diseases. This review includes a summary of seminal findings regarding the impact of ncRNAs on biological and pathological processes, which may be further modified by RNA editing. NcRNAs are non-translated RNAs classified by size and function. Known ncRNAs like miRNAs, smallRNAs (smRNAs), PIWI-interacting RNAs (piRNAs), and lncRNAs play important roles in splicing, DNA methylation, imprinting, and RNA interference. Of note, miRNAs are involved in development and function of the nervous system that is heavily dependent on both RNA editing and the intricate spatiotemporal expression of ncRNAs. This review focuses on the impact of dysregulated A to I editing and ncRNAs in neurodegeneration.

Entities:  

Keywords:  ADARs; RNA editing; long non-coding RNA; microRNAs; non-coding RNAs; snoRNAs

Year:  2013        PMID: 23346095      PMCID: PMC3551214          DOI: 10.3389/fgene.2012.00326

Source DB:  PubMed          Journal:  Front Genet        ISSN: 1664-8021            Impact factor:   4.599


  186 in total

1.  Identification of tandemly-repeated C/D snoRNA genes at the imprinted human 14q32 domain reminiscent of those at the Prader-Willi/Angelman syndrome region.

Authors:  Jérôme Cavaillé; Hervé Seitz; Martina Paulsen; Anne C Ferguson-Smith; Jean-Pierre Bachellerie
Journal:  Hum Mol Genet       Date:  2002-06-15       Impact factor: 6.150

Review 2.  Protein networks in disease.

Authors:  Trey Ideker; Roded Sharan
Journal:  Genome Res       Date:  2008-04       Impact factor: 9.043

3.  5-HT2C receptor agonists: pharmacological characteristics and therapeutic potential.

Authors:  J R Martin; M Bös; F Jenck; J Moreau; V Mutel; A J Sleight; J Wichmann; J S Andrews; H H Berendsen; C L Broekkamp; G S Ruigt; C Köhler; A M Delft
Journal:  J Pharmacol Exp Ther       Date:  1998-08       Impact factor: 4.030

4.  Increased RNA editing in EAAT2 pre-mRNA from amyotrophic lateral sclerosis patients: involvement of a cryptic polyadenylation site.

Authors:  Rachel Flomen; Andrew Makoff
Journal:  Neurosci Lett       Date:  2011-05-05       Impact factor: 3.046

5.  Promoter-associated noncoding RNA from the CCND1 promoter.

Authors:  Xiaoyuan Song; Xiangting Wang; Shigeki Arai; Riki Kurokawa
Journal:  Methods Mol Biol       Date:  2012

6.  Patterns of developmental expression of the RNA editing enzyme rADAR2.

Authors:  M A O'Connell; A P Gerber; R S Zukin
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

7.  A comparative analysis to study editing of small noncoding BC200- and Alu transcripts in brain of prion-inoculated rhesus monkeys (M. Mulatta).

Authors:  Petra Kiesel; Andreas Kues; Franz-Josef Kaup; Walter Bodemer; Toby J Gibson; Hans Zischler
Journal:  J Toxicol Environ Health A       Date:  2012

8.  Editing for an AMPA receptor subunit RNA in prefrontal cortex and striatum in Alzheimer's disease, Huntington's disease and schizophrenia.

Authors:  S Akbarian; M A Smith; E G Jones
Journal:  Brain Res       Date:  1995-11-20       Impact factor: 3.252

Review 9.  X-linked imprinting: effects on brain and behaviour.

Authors:  William Davies; Anthony R Isles; Paul S Burgoyne; Lawrence S Wilkinson
Journal:  Bioessays       Date:  2006-01       Impact factor: 4.345

10.  Adenosine deaminases that act on RNA induce reproducible changes in abundance and sequence of embryonic miRNAs.

Authors:  Cornelia Vesely; Stefanie Tauber; Fritz J Sedlazeck; Arndt von Haeseler; Michael F Jantsch
Journal:  Genome Res       Date:  2012-02-06       Impact factor: 9.043

View more
  22 in total

Review 1.  Epigenetic regulation in Parkinson's disease.

Authors:  Catherine Labbé; Oswaldo Lorenzo-Betancor; Owen A Ross
Journal:  Acta Neuropathol       Date:  2016-06-29       Impact factor: 17.088

2.  Pigmy MicroRNA: surveillance cops in Therapies kingdom.

Authors:  Utpal Bhadra; Pradipta Patra; Jagamohan Chhatai; Manika Pal-Bhadra
Journal:  Mol Med       Date:  2016-09-28       Impact factor: 6.354

3.  Chronic glutamate treatment selectively modulates AMPA RNA editing and ADAR expression and activity in primary cortical neurons.

Authors:  Daniela Bonini; Alice Filippini; Luca La Via; Chiara Fiorentini; Fabio Fumagalli; Marina Colombi; Alessandro Barbon
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

4.  A B-Z junction induced by an A … A mismatch in GAC repeats in the gene for cartilage oligomeric matrix protein promotes binding with the hZαADAR1 protein.

Authors:  Narendar Kolimi; Yogeeshwar Ajjugal; Thenmalarchelvi Rathinavelan
Journal:  J Biol Chem       Date:  2017-09-18       Impact factor: 5.157

Review 5.  Basic biology and therapeutic implications of lncRNA.

Authors:  O Khorkova; J Hsiao; C Wahlestedt
Journal:  Adv Drug Deliv Rev       Date:  2015-05-27       Impact factor: 15.470

Review 6.  What sequencing technologies can teach us about innate immunity.

Authors:  Mays Mohammed Salih; Susan Carpenter
Journal:  Immunol Rev       Date:  2021-11-07       Impact factor: 12.988

Review 7.  Invited review: decoding the pathophysiological mechanisms that underlie RNA dysregulation in neurodegenerative disorders: a review of the current state of the art.

Authors:  Matthew J Walsh; Johnathan Cooper-Knock; Jennifer E Dodd; Matthew J Stopford; Simeon R Mihaylov; Janine Kirby; Pamela J Shaw; Guillaume M Hautbergue
Journal:  Neuropathol Appl Neurobiol       Date:  2015-02       Impact factor: 8.090

Review 8.  RNA-mediated pathogenic mechanisms in polyglutamine diseases and amyotrophic lateral sclerosis.

Authors:  Ho Yin Edwin Chan
Journal:  Front Cell Neurosci       Date:  2014-12-19       Impact factor: 5.505

Review 9.  The Importance of ncRNAs as Epigenetic Mechanisms in Phenotypic Variation and Organic Evolution.

Authors:  Daniel Frías-Lasserre; Cristian A Villagra
Journal:  Front Microbiol       Date:  2017-12-22       Impact factor: 5.640

10.  Selectively Constrained RNA Editing Regulation Crosstalks with piRNA Biogenesis in Primates.

Authors:  Xin-Zhuang Yang; Jia-Yu Chen; Chu-Jun Liu; Jiguang Peng; Yin Rei Wee; Xiaorui Han; Chenqu Wang; Xiaoming Zhong; Qing Sunny Shen; Hsuan Liu; Huiqing Cao; Xiao-Wei Chen; Bertrand Chin-Ming Tan; Chuan-Yun Li
Journal:  Mol Biol Evol       Date:  2015-09-03       Impact factor: 16.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.